NGM621

NGM621 · NGM Biopharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NGM621, covering 2025-07-01 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NGM621 in Participants With Geographic Atrophy [Phase 2]